RAQUEL HENDERSHOT: Open Payments
NPI 1487181665 · RALEIGH, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$983 in 51 payments from 22 companies in 2025. Trend: 2023 $1,426 · 2024 $1,408 · 2025 $983
Food & beverage: $883Education: $100
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 7 | $145 |
| Astellas Pharma US Inc | 3 | $141 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $118 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $69 |
| Lilly USA, LLC | 4 | $66 |
| SANOFI-AVENTIS U.S. LLC | 3 | $55 |
| PFIZER INC. | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 3 | $45 |
| Sumitomo Pharma America, Inc. | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 2 | $33 |
Products named: Korlym, Kerendia, XIFAXAN, TZIELD, MOUNJARO, GEMTESA, Veozah, JARDIANCE.
Industry payments across NC — which companies pay providers there.
